• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

经皮经肝肝内门体分流术治疗脾切除术后合并慢性门静脉闭塞的门静脉高压症

Percutaneous transhepatic intrahepatic portosystemic shunt for treatment of portal hypertension due to chronic portal vein occlusion after splenectomy

摘要:

目的 评价经皮经肝肝内门体分流术(PTIPS)治疗脾切除术后合并慢性门静脉闭塞的门静脉高压症的可行性、有效性及安全性.方法 回顾性分析中山大学附属第三医院2010年1月至2015年3月27例接受PTIPS治疗的脾切除术后合并慢性门静脉闭塞的门静脉高压症患者资料,观察患者手术成功率、并发症及临床随访结果.结果 PTIPS手术成功25例(92.6%),失败2例.没有发生与手术直接相关的严重并发症.手术成功患者的门体静脉压力梯度(PPG)从分流前的平均(22.3±5.7)mmHg(1 mmHg =0.133 kPa)下降至分流后的平均(12.4±3.1)mmHg,差异有统计学意义(P<0.05).对25例手术成功的患者进行随访,中位随访时间为22个月.在随访期间,4例(16.0%)死亡,其中3例(12.0%)死于严重肝硬化所致肝功能衰竭,1例(4.0%)死于脑卒中.4例发生分流道支架闭塞,3例再次球囊扩张及支架植入后恢复通畅;另1例拒绝手术治疗,在术后36个月再次出血.2例(8.0%)术后出现了肝性脑病,1例经内科药物治疗后恢复;另1例发生了3级肝性脑病,术中测量PPG过低,于原分流道内植入一枚直径更小的覆膜支架后肝性脑病得到纠正.其他患者分流道保持通畅且原发症状消失.结论 PTIPS治疗脾切除术后合并慢性门静脉闭塞的门静脉高压症是安全有效的方式.

更多
abstracts:

Objective To study the feasibility and efficacy of percutaneous transhepatic intrahepatic portosystemic shunt (PTIPS) in patients with portal hypertension due to chronic portal vein occlusion after splenectomy.Methods 27 patients who had portal hypertension due to chronic portal vein occlusion after splenectomy underwent PTIPS between December 2010 and March 2015.These patients were enrolled in this retrospective study.The success rates,efficacy,and complications were evaluated.Significance in the differences in the portosystemic pressure gradient (PPG) as measured before and after PTIPS procedure was assessed.Results PTIPS was successfully carried out in 25 patients but failed in 2.No fatal procedural complications were observed.The mean PPG dropped from (22.3 ± 5.7) mmHg to (12.4 ± 3.1) mmHg after successful PTIPS (1 mmHg =0.133 kPa,P <0.05).The median follow-up in the 25 patients with successful PTIPS were 22 months and there were 3 (12.0%) deaths from liver failure due to severe cirrhosis,and 1 death (4.0%) from stroke during the follow-up period.Shunt dysfunction happened in 4 (16.0%) patients.The original symptoms reoccurred in 2 patients (8.0%) and the remaining patients were diagnosed by routine CT or US examination.Three patients recovered after shunt revision with stent implantation or balloon angioplasty,while one patient refused any further therapy except oral medication.This patient suffered from the first episode of rebleeding 36 months after PTIPS.Hepatic encephalopathy developed in 2 (8.0%) patients,1 patient recovered after medical treatment,while the other who developed Grade 3 hepatic encephalopathy recovered after implanting a smaller cover stent.The remaining patients were asymptomatic with patent shunts.Conclusion PTIPS was a feasible,safe,and efficacious treatment for portal hypertension due to chronic portal vein occlusion after splenectomy.

More
作者: 罗骏阳 [1] 李名安 [1] 王皓帆 [1] 吴春 [1] 李征然 [1] 钱结胜 [1] 关守海 [1] 黄明声 [1] 姜在波 [1]
期刊: 《中华肝胆外科杂志》2017年23卷6期 370-374页 ISTICPKUCSCD
栏目名称: 论著
DOI: 10.3760/cma.j.issn.1007-8118.2017.06.003
发布时间: 2017-07-26
基金项目:
广东省科技计划项目(2012B031800085)Science and Technology Planning Project of Guangdong Province,China
  • 浏览:232
  • 下载:80

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷